2020
DOI: 10.3389/fmicb.2020.01766
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the Antifungal Metabolite Chaetoglobosin P From Discosia rubi Using a Cryptococcus neoformans Inhibition Assay: Insights Into Mode of Action and Biosynthesis

Abstract: Cryptococcus neoformans is an important human pathogen with limited options for treatments. We have interrogated extracts from fungal fermentations to find Cryptococcus -inhibiting natural products using assays for growth inhibition, differential thermosensitivity, and synergy with existing antifungal drugs. Extracts from fermentations of strains of Discosia rubi from eastern Texas showed anticryptococcal bioactivity with preferential activity in agar zo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 55 publications
0
4
0
Order By: Relevance
“…The antifungal activity produced by strains was tracked by HPLC microfractionation followed by liquid growth inhibition assay directly in the plates used for fractionation as described previously ( Perlatti, Nichols, Lan, et al, 2020 ). Briefly, the HPLC eluents from an Ace Equivalence C 18 150 × 4.6 mm, 5 μ m, 35°C, 10–100% A over 20 min, holding 100% for 4 min, 1.0 ml min −1 were collected with a fraction collector.…”
Section: Methodsmentioning
confidence: 99%
“…The antifungal activity produced by strains was tracked by HPLC microfractionation followed by liquid growth inhibition assay directly in the plates used for fractionation as described previously ( Perlatti, Nichols, Lan, et al, 2020 ). Briefly, the HPLC eluents from an Ace Equivalence C 18 150 × 4.6 mm, 5 μ m, 35°C, 10–100% A over 20 min, holding 100% for 4 min, 1.0 ml min −1 were collected with a fraction collector.…”
Section: Methodsmentioning
confidence: 99%
“…7) 48 . PydY and its homologues, namely ScpY 48 , PN3-20 49 , G73 50 , and MGG_15096 51 , have been found in the biosynthetic pathways of a few fungal polyketide-nonribosomal peptide hybrid molecules; however, their prevalence in fungal natural product pathways has not been investigated. The global genome analysis resulted in the detection of more than 300 BGCs with a pydY homologue (Supplementary Fig.…”
Section: Discussionmentioning
confidence: 99%
“…More specifically, the upregulated quelling candidates are predicted to encode 16 chitinases, 17 glucanases, and seven mannanases (Table 1, and Supplementary File 1) that were demonstrated in the biocontrol agent Trichoderma to be involved in inhibiting the growth of phytopathogens (Lopes et al, 2012;Geraldine et al, 2013;Vos et al, 2015). Of the ten differentially upregulated biosynthetic gene clusters, seven are predicted to produce antifungal compounds such as (-)-Mellein, Chaetoglobosin, and Oxaleimide (Chen et al, 2015;Perlatti et al, 2020;Reveglia et al, 2020), and putative cytotoxic compounds such as Sansalvamide, Communesin, Squalestatin S1, and Wortmanamide (see Table 2; Belofsky et al, 1999;Trost and Osipov, 2015;Bonsch et al, 2016;Hai and Tang, 2018). The compounds synthesized by the remaining three clusters are unknown but are assumed to act as antifungals as well.…”
Section: Gene Expression Of Ec4 When Co-cultured With the Pathogenmentioning
confidence: 99%